Publicaciones en las que colabora con Ainara Vallejo Illarramendi (10)

2024

  1. Dysregulated FOXO1 activity drives skeletal muscle intrinsic dysfunction in amyotrophic lateral sclerosis

    Acta Neuropathologica, Vol. 148, Núm. 1

2023

  1. Pharmacokinetic Evaluation of New Drugs Using a Multi-Labelling Approach and PET Imaging: Application to a Drug Candidate with Potential Application in Neuromuscular Disorders

    Biomedicines, Vol. 11, Núm. 2

2006

  1. Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients

    Schizophrenia Research

  2. GLT-1 down-regulation induced by clozapine in rat frontal cortex is associated with synaptophysin up-regulation

    Journal of Neurochemistry, Vol. 99, Núm. 1, pp. 134-141

  3. Increased expression and function of glutamate transporters in multiple sclerosis

    Neurobiology of Disease, Vol. 21, Núm. 1, pp. 154-164

2005

  1. A novel alternative splicing form of excitatory amino acid transporter 1 is a negative regulator of glutamate uptake

    Journal of Neurochemistry, Vol. 95, Núm. 2, pp. 341-348

  2. Clozapine reduces GLT-1 expression and glutamate uptake in astrocyte cultures

    GLIA, Vol. 50, Núm. 3, pp. 276-279

  3. Increased expression of the astrocytic glutamate transporter GLT-1 in the prefrontal cortex of schizophrenics

    GLIA, Vol. 49, Núm. 3, pp. 451-455

2002

  1. Activation of phospholipase D-2 by P2X7 agonists in rat submandibular gland acini

    Journal of Lipid Research, Vol. 43, Núm. 8, pp. 1244-1255

2001

  1. The expression of glutamate transporter GLT-1 in the rat cerebral cortex is down-regulated by the antipsychotic drug clozapine

    Molecular Psychiatry, Vol. 6, Núm. 4, pp. 380-386